` APDN (Applied DNA Sciences Inc) vs S&P 500 Comparison - Alpha Spread

APDN
vs
S&P 500

Over the past 12 months, APDN has underperformed S&P 500, delivering a return of -99% compared to the S&P 500's 9% growth.

Stocks Performance
APDN vs S&P 500

Loading
APDN
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
APDN vs S&P 500

Loading
APDN
S&P 500
Difference
www.alphaspread.com

Performance By Year
APDN vs S&P 500

Loading
APDN
S&P 500
Add Stock

Competitors Performance
Applied DNA Sciences Inc vs Peers

S&P 500
APDN
0KHE
TMO
DHR
207940
Add Stock

Applied DNA Sciences Inc
Glance View

Market Cap
2.5m USD
Industry
Life Sciences Tools & Services

Applied DNA Sciences, Inc. engages in the developing and marketing DNA-based technology solutions utilizing LinearDNA, large-scale polymerase chain reaction (PCR) based manufacturing platform. The company is headquartered in Stony Brook, New York and currently employs 78 full-time employees. The company went IPO on 2001-08-24. The firm is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. Applied DNA also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.

APDN Intrinsic Value
35.43 USD
Undervaluation 87%
Intrinsic Value
Price
Back to Top